Donoghue Forlines LLC Novo Cure LTD Transaction History

Donoghue Forlines LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$56.6 - $89.9 $492,872 - $782,849	-8,708 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $158,976 - $223,386	2,643 Added 43.58%	8,708 $721,000
Q4 2021 Feb 11, 2022	BUY	$75.08 - $121.99 $57,361 - $93,200	764 Added 14.41%	6,065 $455,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $129,878 - $217,506	1,118 Added 26.73%	5,301 $616,000
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $44,205 - $76,471	-339 Reduced 7.5%	4,183 $928,000
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $34,130 - $52,296	275 Added 6.48%	4,522 $598,000
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $476,343 - $739,572	4,247 New	4,247 $735,000
Q4 2019 Jan 27, 2020	SELL	$68.3 - $93.8 $2.11 Million - $2.89 Million	-30,856 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$61.86 - $97.8 $1.91 Million - $3.02 Million	30,856 New	30,856 $2.31 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.